Intensity-modulated radiation therapy (IMRT) represents a significant technological advancement in the ability to deliver highly conformal radiation therapy. Thanks to increased availability, general clinical implementation has become progressively more common. However, there are several precautions worthy of comment regarding the clinical applications of IMRT.
In theory, the increased irradiated volume and leakage radiation that occasionally accompanies IMRT could contribute to unanticipated complications and safety concerns. The protracted delivery time of IMRT with the associated increased linac monitor units can result in photoactivation of elements within the linac collimator, thereby inadvertently increasing radiation exposure to patients and staff when high-energy photons are used. The increased volumes of normal tissue exposed to lower doses of radiation through IMRT theoretically could promote carcinogenesis and complications due to the bystander effect, low-dose hyper-radiosensitivity, and diminished repair of double strand DNA breaks at very low doses. Tumor control may be adversely affected by the lower radiation dose-rates of delivery sometimes associated with IMRT as well the occasionally seen low dose “cold shoulder” on the dose-volume histograms. Unusual clinical reactions can appear as a result of the complex, unfamiliar dose-distributions occasionally generated by IMRT treatment planning. Here we discuss some of the precautions worthy of consideration when using IMRT and how these might be addressed in routine practice.
WelshJ. and HowardS.Fractionated Low Dose-rate Whole Abdominal Irradiation for Recurrent Malignancy. Cancer J.7, 547–548 (2001).
2.
TomeW., WelshJ. S., and HowardS. P.Fractionated Low Dose Rate Irradiation: A Unique Application of Tomotherapy. Proceedings of the 6th International Conference on Dose, Time, and Fractionation in Radiation Oncology: Biological and Physical Basis of IMRT and Tomotherapy, pp 48. Sept. (2001).
3.
WangJ. Z., LiX. A., D'SouzaW. D., and StewartR. D.Impact of Prolonged Fraction Delivery Times on Tumor Control: A Note of Caution for IMRT. Int. J. Rad. Oncol. Biol. Phys.57, 543–552 (2003).
4.
FowlerJ. F., WelshJ. S., and HowardS. P.Loss of Biological Effect in Prolonged Fraction Delivery. Int. J. Radiat. Oncol. Biol. Phys.59, 242–249 (2004).
5.
MuX., LofrothP. O., KarlssonM., and ZackrissonB.The Effect of Fraction Time in Intensity Modulated Radiotherapy: Theoretical and Experimental Evaluation of an Optimization Problem. Radiother. Oncol.68, 181–187 (2003).
6.
ToméW. A., WelshJ. S., and FowlerJ. F.The Effect of Fraction Time in Intensity Modulated Radiotherapy: Theoretical and Experimental Evaluation of an Optimization Problem (The Real Conclusions). Radiother. Oncol.72, 113–114 (2004).
7.
WelshJ. S., HowardS. P., and FowlerJ. F.Dose Rate in External Beam Radiotherapy for Prostate Cancer: An Overlooked Confounding Variable?Urology.62, 204–206 (2003).
8.
ShibamotoY., ItoM., SugieC., OginoH., and HaraM.Recovery from Sublethal Damage During Intermittent Exposures in Cultured Tumor Cells: Implications for Dose Modification in Radiosurgery and IMRT. Int. J. Radiat. Oncol. Biol. Phys.59, 1484–1490 (2004).
9.
RawlinsonJ. A., IslamM. K., and GalbraithD. M.Dose to Radiation Therapists from Activation at High-energy Accelerators Used for Conventional and Intensity-modulated Radiation Therapy. Med. Phys.29, 598–608 (2002).
10.
PerrinB., WalkerA., and MackayR.A Model to Calculate the Induced Dose Rate Around an 18 MV ELEKTA Linear Accelerator. Phys. Med. Biol.48, N75–81 (2003).
11.
FollowillD. S., StovallM. S., KryS. F., and IbbottG. S.Neutron Source Strength Measurements for Varian, Siemens, Elekta, and General Electric Linear Accelerators. J. Appl. Clin. Med. Phys.4, 189–194 (2003).
12.
LeeN. C., ChuangJ., QuiveyT.Skin Toxicity Due to Intensity-modulated Radiotherapy for Head-and-Neck Carcinoma. Int. J. Rad. Oncol. Biol. Phys.53, 630–637 (2002).
13.
ToméW. A. and FowlerJ. F.On Cold Spots in Tumor Subvolumes. Med. Phys.29, 1590–1598 (2002).
14.
PerksJ. R., LehmannJ., YangC. C.RSNA Sci Assembly and Ann Meeting Prog., pp. 732 (2004).
15.
MackieT., KissikiM., JerajR., ToméW., FenwickJ., OliveraG., and RitterM.Intergal Dose in External Beam Photon Radiotherapy. Med. Phys.31, 1721 (2004).
16.
VerellenD. and VanhavereF.Risk Assessment of Radiation-induced Malignancies Based on Whole-body Equivalent Dose Estimates for IMRT Treatment in the Head and Neck Region. Radiother Oncol.53, 199–203 (1999).
17.
HallE. J. and WuuC.-S.Radiation-induced Second Cancers: The Impact of 3D-CRT and IMRT. Int. J. Radiat. Oncol. Biol. Phys.56, 83–88 (2003).
18.
GlatsteinE.Intensity-modulated Radiation Therapy: The Inverse, the Converse, and the Perverse. Semin Radiat Oncol.12, 272–281 (2002).
19.
GoffmanT. E. and GlatsteinE.Intensity-modulated Radiation Therapy. Radiat. Res.158, 115–117 (2002).
20.
SawantS. G., Randers-PehrsonG., GeardC. R.The Bystander Effect in Radiation Oncogenesis: I. Transformation in C3H 10 T1/2 Cells In Vitro can be Initiated in the Unirradiated Neighbors of Irradiated Cells. Radiat. Res.155, 397–401 (2001).
21.
MillerR. C., Randers-PehrsonG., GeardC. R.The Oncogenic Transforming Potential of the Passage of Single Alpha Particles Through Mammalian Cell Nuclei. Proc Natl Acad Sci.96, 19–22 (1999).
22.
RothkammK. and LobrichM.Evidence for a Lack of DNA Double-strand Break Repair in Human Cell Exposed to Very Low X-ray Doses. Proc. Natl. Acad. Sci.100, 5057–5062 (2003).
23.
WelshJ. S., PatelR. R., RitterM. A., HarariP., MackieT. R., and MehtaM. P.Helical Tomotherapy: An Innovative Technology and Approach to Radiation Therapy. Technology in Cancer Research and Treatment.1, 55–63 (2002).
24.
JoinerM. C., MarplesB., LambinP.Low-dose Hypersensitivity: Current Status and Possible Mechanisms. Int J Radiat Oncol Biol Phys.49, 379–389 (2001).
25.
MarplesB., WoutersB. G., CollisS. J., ChalmersA. J., and JoinerM. C.Low-dose Hyper-radiosensitivity: A Consequence of Ineffective Cell Cycle Arrest of Radiation-damaged G2-phase Cells. Radiat Res.161, 247–255 (2004).
26.
NagasawaH. and LittleJ. B.Induction of Sister Chromatid Exchanges by Extremely Low Doses of Alpha-particles. Cancer Res.52, 6394–6396 (1992).
27.
NagasawaH. and LittleJ. B.Unexpected Sensitivity to the Induction of Mutations by Very Low Doses of Alpha-particle Radiation: Evidence for a Bystander Effect. Radiat. Res.153, 552–557 (1999).
28.
HuoL., NagasawaH., and LittleJ. B.HPRT Mutants Induced in Bystander Cells by Very Low Fluences of Alpha Particles Result Primarily from Point Mutations. Radiat. Res.156, 521–525 (2001).
29.
MackieT. R., KapatoesJ., RuchalaK., LuW., WuC., OliveraG., ForrestL., TomeW., WelshJ., JerajR., HarariP., ReckwerdtP., PaliwalB., RitterM., KellerH., FowlerJ., and MehtaM.Image Guidance for Precise Conformal Radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.56, 89–105 (2003).
30.
WelshJ. S., BradleyK., RuchalaK. J., MackieT. R., ManonR., PatelR., WiederholtP., LockM., HuiS., and MehtaM. P.Megavoltage Computed Tomography Imaging: A Potential Tool to Guide and Improve the Delivery of Thoracic Radiation Therapy. Clin. Lung Cancer5, 303–306 (2004).
31.
ToméW. A. and FowlerJ. F.Selective Boosting of Tumor Subvolumes. Int. J. Rad. Oncol. Biol. Phys.48, 593–599 (2000).
32.
BenedictS. H., LinP. S., ZwickerR. D., HuangD. T., and Schmidt-UllrichR. K.The Biological Effectiveness of Intermittent Irradiation as a Function of Overall Treatment Time: Development of Correction Factors for Linac-based Stereotactic Radiotherapy. Int. J. Rad. Oncol. Biol. Phys.37, 765–769 (1997).
33.
MorganW. F., NaqviC., YuC., SmithL. E., and BoseM.Does the Time Required to Deliver IMRT Reduce its Biological Effectiveness?Int. J. Rad. Oncol. Biol. Phys.54, 222 (2002).
34.
SugieC., ItoM., OginoH., MiyamotoA., FukayaN., and ShibamotoY.Changes in the Effect of Radiation Due to Intermittent Exposures in Murine Tumors: Comparison with In Vitro Results. RSNA Sci. Assembly and Ann. Meeting. Prog., pp. 299 (2004).
35.
ZhangT., JerajR., KellerH., LuW., OliveraG. H., McNuttT. R., MackieT. R., and PaliwalB.Treatment Plan Optimization Incorporating Respiratory Motion. Med. Phys.31, 1576–1586 (2004).
